Inhibition of PERK-eIF2α-ATF4 signaling enhances the antiviral effects of resveratrol-loaded nanoparticles against enterovirus 71 in hand, foot, and mouth disease
Archives of Virology · 2025
DOI: 10.1007/s00705-025-06392-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Virology, 2025. Verfasst von Bin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The First Hospital of Jilin University, No.1 Xinmin Street, 130021, Changchun, China. Hauptthemen laut MEDLINE: Enterovirus A, Human, eIF-2 Kinase, Activating Transcription Factor 4, Eukaryotic Initiation Factor-2. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Science and Technology Department of Jilin Province, Bethune Special Project.
Abstract (Originalsprache)
Resveratrol-loaded nanoparticles (RES-NPs) have been found to reduce enterovirus 71 (EV71) replication in EV71-infected-rhabdosarcoma (RD) cells. However, the specific mechanism by which RES-NPs prevent EV71 infection in RD cells remains largely unclear. The cell viability, inflammatory response, and oxidative stress in EV71-infected RD cells were assessed. Inhibition of protein kinase RNA-like endoplasmic reticulum kinase (PERK) significantly increased the viability of infected RD cells, reduced inflammation and oxidative stress, and led to a significant decrease in EV71 mRNA levels. Furthermore, treatment of infected RD cells with RES-NPs significantly increased cell viability and alleviated inflammation and oxidative stress, and these effects were further enhanced by inhibition of PERK. RES-NP treatment also resulted in a decrease in phosphorylated PERK, phosphorylated eukaryotic translation initiation factor 2α (eIF2α), and activating transcription factor 4 (ATF4) levels in infected RD cells, and the levels of these protein were further reduced by treatment with the PERK inhibitor. RES-NPs were found to inhibit EV71 infection by reducing virus-induced inflammatory responses and oxidative stress in RD cells, possibly through inactivation of the PERK-eIF2α-ATF4 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, The First Hospital of Jilin University, No.1 Xinmin Street, 130021, Changchun, China.
- Department of Infectious Diseases, The First Hospital of Jilin University, No.1 Xinmin Street, 130021, Changchun, China. du_na@jlu.edu.cn.
Förderung
- Science and Technology Department of Jilin Province, Bethune Special Project
Zitieren
APA
Wang, B., Che, L., Zhang, P., Sun, L., Yu, Y., & Du, N. (2025). Inhibition of PERK-eIF2α-ATF4 signaling enhances the antiviral effects of resveratrol-loaded nanoparticles against enterovirus 71 in hand, foot, and mouth disease. Archives of Virology. https://doi.org/10.1007/s00705-025-06392-5
Vancouver
Wang B, Che L, Zhang P, Sun L, Yu Y, Du N. Inhibition of PERK-eIF2α-ATF4 signaling enhances the antiviral effects of resveratrol-loaded nanoparticles against enterovirus 71 in hand, foot, and mouth disease. Archives of Virology. 2025. doi:10.1007/s00705-025-06392-5
BibTeX
@article{Wang2025,
author = {Wang, Bin and Che, Lihe and Zhang, Peng and Sun, Luyao and Yu, Yue and Du, Na},
title = {Inhibition of PERK-eIF2α-ATF4 signaling enhances the antiviral effects of resveratrol-loaded nanoparticles against enterovirus 71 in hand, foot, and mouth disease},
journal = {Archives of Virology},
year = {2025},
doi = {10.1007/s00705-025-06392-5}
}
EUVIMED